The following table summarizes the Company’s other current assets for each of the periods indicated:


	As of June 30, 2025		As of December 31, 2024
	(in thousands)
Collaboration and other receivables	$	73,256	$	34,608
Prepaid maintenance services		15,592		13,407
Prepaid clinical and pre-clinical expenses		10,821		10,220
Tax-related receivables and prepaids		7,244		13,132
Prepaid insurance		4,113		3,668
Prepaid commercial expenses		3,729		3,371
Interest receivable		1,800		1,970
Other		11,039		10,085
Total other current assets	$	127,594	$	90,461

The following table summarizes the Company’s other non-current assets for each of the periods indicated:


	As of June 30, 2025		As of December 31, 2024
	(in thousands)
Intangible assets, net	$	30,522	$	26,887
Manufacturing-related deposits and prepaids		25,436		25,964
Restricted cash*		15,579		15,579
Prepaid maintenance services		4,218		4,381
Other		7,382		3,394
Total other non-current assets	$	83,137	$	76,205

* The Company had $15.6 million in restricted cash included in other non-current assets on the Company’s unaudited condensed consolidated balance sheets as of both June 30, 2025 and December 31, 2024. Restricted cash for both periods relates to (i) letters of credit established under the Company’s various property leases that serve as security for potential future default of lease payments, (ii) a letter of credit established under a certain commercial supply agreement and (iii) collateralized cash for the Company’s credit cards. The restricted cash is unavailable for withdrawal or use for general obligations.